
Number of publications published per year by Maggioni, Marco. (Source : PubMed)

Distribution of publications types for Maggioni, Marco. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease.
Hepatology
2010;51;4

Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease.
Gut
2010;59;2
Human cholangiocarcinoma development is associated with dysregulation of opioidergic modulation of cholangiocyte growth.
Dig Liver Dis
2009;41;7

Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients.
J. Hepatol.
2009;50;1
Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma.
BMC Cancer
2009;9
Screening anxious-depressive symptoms and pain in medical inpatients.
Panminerva Med
2008;50;3

Complete pathological response of hepatocellular carcinoma with systemic combination chemotherapy.
Anticancer Drugs
2008;19;8
Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitis.
Diabetes
2008;57;5
Manifold parametrizations by eigenfunctions of the Laplacian and heat kernels.
Proc. Natl. Acad. Sci. U.S.A.
2008;105;6

Solitary fibrous tumor of the pleura presenting with syncope episodes when coughing.
World J Surg Oncol
2008;6
[ See timeline ] [ See all publications ]
means that Maggioni, Marco has 14 papers cited a least 14 times - methodology
Department of Internal Medicine, Ospedale Maggiore Policlinico Mangiagalli Regina Elena IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), University of Milan, Milan, Italy.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.